Abstract: Provided herein are iron chelating compounds, compositions containing such compounds and methods of using the compounds in treating various aesthetic skin conditions. The iron chelating compositions may be administered topically or orally. Treating the aesthetic skin conditions includes preventing onset or delaying progression of the aesthetic skin condition.
Type:
Application
Filed:
September 20, 2019
Publication date:
October 14, 2021
Applicant:
TAUTONA GROUP IP HOLDING COMPANY, L.L.C.
Abstract: A transdermal patch for the treatment of Sickle Cell Ulcers is provided. The patch can facilitate the delivery of an iron chelator, such as DFO. The DFO can be encapsulated in a reverse micelle to enhance penetration into and absorption by the dermis. The patch can be used to accelerate healing and reduce pain associated with Sickle Cell Ulcers.
Type:
Application
Filed:
March 27, 2019
Publication date:
April 22, 2021
Applicant:
TAUTONA GROUP IP HOLDING COMPANY, L.L.C.